Literature DB >> 731418

Effect of route of administration and distribution on drug action.

L Z Benet.   

Abstract

The extent and time course of drug action can be markedly affected by the route of drug administration into the patient as well as the pattern of drug distribution within the patient. Drugs which are rapidly cleared by hepatic processes will show a decreased extent of availability following oral administration due to metabolism of drug on its first pass through the liver. The magnitude of this first pass will depend on the blood flow to the liver and the intrinsic clearing ability of the liver (i.e., the ability of the organ to eliminate the drug independent of the rate at which drug is brought to the organ). Drug distribution in the patient will depend on the blood flow to various sites in the body as well as the partition coefficient of the drug between the blood and the distributive organs. Protein binding both in the plasma and in the tissues will markedly affect this distribution. However, free drug concentrations are generally relieved to be the effective determinant in drug therapy. Often a redistribution due to changes in protein binding will have little effect on the therapeutic efficacy since, although total drug distribution changes, free concentrations in the plasma remain essentially similar.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 731418     DOI: 10.1007/bf01062110

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  26 in total

1.  An electric analogue for uptake and exchange of inert gases and other agents.

Authors:  W W MAPLESON
Journal:  J Appl Physiol       Date:  1963-01       Impact factor: 3.531

2.  Plasma concentrations of propoxyphene in man. I. Following oral administration of the drug in solution and capsule forms.

Authors:  J G Wagner; P G Welling; S B Roth; E Sakmar; K P Lee; J E Walker
Journal:  Int Z Klin Pharmakol Ther Toxikol       Date:  1972-02

3.  Antiarrhythmic effectiveness of intramuscular lidocaine: influence of different injection sites.

Authors:  M L Schwartz; M B Meyer; B G Covino; R M Narang; V Sethi; A J Schwartz; P Kamp
Journal:  J Clin Pharmacol       Date:  1974 Feb-Mar       Impact factor: 3.126

4.  Morphine metabolism in man.

Authors:  S F Brunk; M Delle
Journal:  Clin Pharmacol Ther       Date:  1974-07       Impact factor: 6.875

5.  Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans.

Authors:  P D Thomson; K L Melmon; J A Richardson; K Cohn; W Steinbrunn; R Cudihee; M Rowland
Journal:  Ann Intern Med       Date:  1973-04       Impact factor: 25.391

6.  Absorption kinetics of aspirin in man following oral administration of an aqueous solution.

Authors:  M Rowland; S Riegelman; P A Harris; S D Sholkoff
Journal:  J Pharm Sci       Date:  1972-03       Impact factor: 3.534

7.  Influence of route of administration on drug availability.

Authors:  M Rowland
Journal:  J Pharm Sci       Date:  1972-01       Impact factor: 3.534

8.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

9.  Pharmacokinetics of salicylamide elimination in man.

Authors:  G Levy; T Matsuzawa
Journal:  J Pharmacol Exp Ther       Date:  1967-05       Impact factor: 4.030

10.  Pharmacokinetics of ampicillin trihydrate, sodium ampicillin, and sodium dicloxacillin following intramuscular injection.

Authors:  J T Doluisio; J C LaPiana; L W Dittert
Journal:  J Pharm Sci       Date:  1971-05       Impact factor: 3.534

View more
  15 in total

1.  Pharmacokinetics of FCE 22891, a new oral penem.

Authors:  A Saathoff; H Lode; B Hampel; K M Deppermann; K Borner; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

2.  Pharmacokinetics and serum bactericidal activities of quinolones in combination with clindamycin, metronidazole, and ornidazole.

Authors:  M Boeckh; H Lode; K M Deppermann; S Grineisen; F Shokry; R Held; K Wernicke; P Koeppe; J Wagner; C Krasemann
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

3.  Pharmacokinetics of ofloxacin after parenteral and oral administration.

Authors:  H Lode; G Höffken; P Olschewski; B Sievers; A Kirch; K Borner; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

4.  MucoJet: a novel noninvasive buccal mucosa immunization strategy.

Authors:  Hetron Mweemba Munang'andu
Journal:  Ann Transl Med       Date:  2018-02

5.  Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora.

Authors:  M Ritz; H Lode; M Fassbender; K Borner; P Koeppe; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

6.  Bioavailability and metabolism of potassium phosphanilate in laboratory animals and humans.

Authors:  F H Lee; D R Van Harken; M Vasiljev; R D Smyth; G H Hottendorf
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

7.  A physiological model for the pharmacokinetics of methylene chloride in B6C3F1 mice following i.v. administrations.

Authors:  M J Angelo; K B Bischoff; A B Pritchard; M A Presser
Journal:  J Pharmacokinet Biopharm       Date:  1984-08

8.  Pharmacokinetics of loracarbef and interaction with acetylcysteine.

Authors:  S Roller; H Lode; I Stelzer; K M Deppermann; M Boeckh; P Koeppe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

9.  Pharmacokinetics of ciprofloxacin after oral and parenteral administration.

Authors:  G Höffken; H Lode; C Prinzing; K Borner; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

10.  Relative bioavailability of a paracetamol suppository.

Authors:  P Seideman; G Alván; R S Andrews; A Labross
Journal:  Eur J Clin Pharmacol       Date:  1980-06       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.